Biotech China 2014

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2010 Notch activation enhances IFNγ secretion by human peripheral blood and decidual NK cells The Journal of Reproductive Immunology. 84(1):1-7.
2. 2010 The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination. Nature Immunol. 11(9):806-13. Epub 2010 Aug 8.
3. 2010 Tumor Immunoediting by NKp46. J Immunol. 15;184(10):5637-5644. Epub 2010 Apr 19.
4. 2010 The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells. J Immunol. 184(6): 2761-2768. Epub 2010 Feb 17.
5. 2010 NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus. J Virol. 84(8): 3789-3797. Epub 2010 Feb 10.
6. 2010 Killing of avian and Swine influenza virus by natural killer cells. J Virol. 84(8):3993-4001. Epub 2010 Feb 3.
7. 2010 Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface 2010 PLoS One, Jan 28;5(1):e8941.
8. 2010 The NKp46 activating receptor is essential for type 1 diabetes development. Nature Immunology, 11(2), 121-128.
9. 2010 Methods to identify and characterize different NK cell receptors and their ligands. Methods Mol Biol. 612: 249-273.
10. 2009 Enhanced in vivo growth of lymphoma tumors in the absence of the NK activating receptor NKp46/NCR1 J. Immunol 182: 2221-2230., 6.068; 13/119; 6:6
11. 2009 Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe. 5: 376-385.
12. 2009 Analysis of human cytomegalovirus encoded-microRNAs activity during infection. J Virol. 83(20):10684-10693
13. 2009 Dynamic behavior of NK cells during activation in lymph nodes. Blood. 114(15): 3227-3234
14. 2009 An integrated view of NKG2D ligands regulation. Immunology, 128(1): 1-6.
15. 2009 The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J Immunol. 183(10): 6579-6587.
16. 2009 The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc Natl Acad Sci U S A. 106(42): 17858-17863.
17. 2008 H5-type Influenza Hemagglutinin is Functionally Recognized by the Natural Killer Activating Receptor, NKp44. J Virol. 82: 2028-2032 5.332; 3/25; 2;2
18. 2008 Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity. 29: 958-970.
19. 2008 Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D Nature Immunology, 9: 1065-1073. 26.382; 3/263; 20:20
20. 2008 Endometrial Natural Killer Cells are Special Immature Cells that Await Pregnancy J. Immunol, 181: 1869-1876. 6.068; 13/119; 0
21. 2008 Influenza virus infection augments NK cell inhibition through the reorganization of MHC class I proteins JVI, 82: 8030-8037. 5.332; 3/25; 0
22. 2008 Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy PLoS ONE. 2008 May 14;3(5):e2150. 3.238; 13/37; 2;2
23. 2008 Immunological assessment of familial tinea corporis J Eur Acad Dermatol Venereol. 22: 871-874. 1.437; 20/41; 0
24. 2008 Expression of Ligands to NKp46 in Benign and Malignant Melanocytes J Invest Dermatol. 128: 972-979. 0.28 98/178: 0
25. 2008 Altered Glycosylation of Recombinant NKp30 Hampers Binding to Heparan Sulfate: a Lesson for the Use of Recombinant Immuno-Receptors as an Immunological tool Glycobiology. 18: 28-41. 2.901; 51/119; 0
26. 2007 HLA-G complexes are observed on the cell surface Hum Immunol. 68(4): 227-232. 2.901; 51/119; 0
27. 2007 NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome. Blood 109(10): 4306-4312. Epub 2007 Jan 25. 10.896; 2/63; 5;5
28. 2007 Intercellular transfer of CEA from tumor cells to NK cells J. Immunol, 317: 376-381. 6.068; 13/119; 1;1
29. 2007 Intracellular cysteine residues in the tail of MHC class I proteins are crucial for extracellular recognition by LIR11 J. Immunol, 179: 3655-3661. 6.068; 13/119; 1;1
30. 2007 When killers become helpers Trends Immunol. 28(5): 201-206. 9.480; 7/119; 17;15
31. 2007 The unique properties of human NK cells in the uterine mucosa Placenta. 2007 Nov 24; [Epub ahead of print] 3.238; 13/37; 4;4
32. 2007 Neisserial outer membrane vesicles bind the co-inhibitory receptor CEACAM1 and suppress CD4+ T lymphocyte function Infect Immun. Jul 9; [Epub ahead of print]. 3.996; 28/119; 6.068; 13/119; 6;6
33. 2007 Host immune system gene targeting by a viral miRNA. Science. 317: 376-381. 26.372; 2/50; 61;61
34. 2007 Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin Apoptosis. 12(7):1129-1142. 3.003, 60/128; 3;3
35. 2007 CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells J Exp Med. 204: 2569-2478. 15.612; 5/119; 34;34
36. 2007 The Expression Level of Ligands for Natural Killer Cell Receptors Predicts Response to Bacillus Calmette-Guerin Therapy: A Pilot Study J Urol. 178:2660-2664. 4.053; 8/55; 2;2
37. 2007 Manipulation of NK cytotoxicity by the IAP family member Euro J Immunol. 4.812; 52/263; 37:3467-3476. 2;2
38. 2007 CD100 on NK Cells Enhance IFNgamma Secretion and Killing of Target Cells Expressing CD72 PLoS ONE. 2(9): e818. 3.238; 13/37; 1;1
39. 2007 A phenotypic and functional characterization of NK cells in adenoids. J Leukoc Biol. 2007 Aug 3; [Epub ahead of print] 4.128; 50/156;
40. 2006 CEACAM1 (CD66a) promotes human monocyte survival via a phosphatidylinositol 3-kinase- and AKT-dependent pathway J Biol Chem. 281(51): 39179-93. 5.581; 40/263; 6;5
41. 2006 Lethal influenza infection in the absence of Ncr1 Nature Immunol, 7: 517-523. 26.218; 3/119; 54;47
42. 2006 Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions J Immunol. 177(9): 6062-71. 26.218; 3/119; 3;3
43. 2006 Decidual NK Cells Regulate Key Developmental Processes at the Human Maternal-Fetal Interface Nature Medicine. 12: 1065-1074. 26.382; 3/263; 133;127
44. 2006 Reduced KIR2DL1 recognition of MHC class I molecules presenting phosphorylated peptides J Immunol, 176: 6762-6769. 6.068; 13/119; 2;2
45. 2006 Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells Stem Cells. 24, 221-229. 7.531; 5/138; 78;78
46. 2006 Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol. 16(5): 348-58 7.510; 11/132; 14;10
47. 2005 Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEACAM1 J. Immunol.174, 6692-6701. 6.068; 13/119; 21;16
48. 2005 Proteomic analysis of human natural killer cells: insights on new potential NK immune functions Mol Immunol. 42: 425-431. 3.742; 79/263; 8;6
49. 2005 Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency Blood. 106, 3465-3473. 10.896; 2/63; 5;5
50. 2005 The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules. J. Immunol. 175, 4866-4874. 6.068; 13/119; 24;23
51. 2005 Natural Killer cells and CEACAM1 in Ankylosing Spondylitis Int Immunol. 17, 837-845. 3.290; 43/119; 5;4
52. 2005 A novel interaction between the HCMV pp65 protein and the NK activating receptor NKp30 leads to a general inhibition of NK killing Nature. Immunol. 6, 515-523. 26.218; 3/119; 63;54
53. 2005 Is Expressed and Functional on Human Eosinophils. J. Immunol. 174: 110-118. 6.068; 13/119; 23;23
54. 2004 The Mechanisms Controlling NK Cell Autoreactivity in TAP2-Deficient Patients Blood. 103: 1770-1778. 10.896; 2/63; 29;18
55. 2004 The mechanisms controlling the recognition of tumor and virus infected cells by NKp46 Blood, 103: 664-672. 10.896; 2/63; 49;36
56. 2004 Novel APC-like Properties of Human NK Cells Directly Regulate T cell Activation in Health and Disease J. Clin. Invest. 114:1612-1623. 16.915; 2/81; 54;46
57. 2004 Novel Insights on Human Natural Killer Cells Immunological Modalities Revealed by Gene Expression Profiling J. Immunol. 173: 6547-6563; 6.068; 13/119; 38;30
58. 2004 The Critical Role of Residues 43R and 44Q of Carcinoembryonic Antigen Cell Adhesion Molecules-1 in the Protection from Killing by Human NK Cells. J Immunol. 173: 3732-3739; 6.702; 11/114. 15;12
59. 2004 Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients. Eur J Immunol.34: 2138-48; 4.662; 19/119; 9;6
60. 2004 MHC class I-independent recognition of the NK activating receptor KIR2DS4 J Immunol. 173: 1819-1825; 6.068; 13/119; 30;29
61. 2004 Recognition of Mycoplasma hyorhinis by CD99-Fc molecule Eur J. Immunol. 34: 2032-2040. 4.662; 19/119; 4;3
62. 2004 Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy Bone Marrow Transplant. 33: 1137-1141. 3.000; 56/132; 4;2
63. 2004 Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus. Eur J Immunol. 34: 1164-1174. 4.662; 19/119; 17;16
64. 2004 Expression of KIR2DL1 on the entire NK cell population: A possible novel immunodeficiency syndrome Blood. 103:1965-1966 as correspondences to the editor. 10.896; 2/63; 20;19
65. 2003 Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice Blood. 102: 1951-1958. 10.896; 2/63;30;28
66. 2003 Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function J. Immunol. 171: 1343-1351, 6.068; 13/119; 33;25
67. 2003 Special organization of the HLA-G protein on the cell surface. Human Immunol, 64: 1011-1016, 2.901; 51/119; 13;11
68. 2003 Caspae-mediated cleavage converts livin from an anti-apoptotic to a pro-apoptotic factor: Implications for drug-resistance melanoma Cancer Res. 63: 6340-6349, 7.672; 8/132; 41;39
69. 2003 Enhanced recognition of human NK receptors after influenza virus infection J. Immunol. 17: 915-923, 6.068; 13/119; 18;11
70. 2003 CXCL12 expression by invasive decidual trophoblasts induces the specific migration of CD16 negative human natural killer cells Blood.102: 1569-1577, 10.896; 2/63; 83;72
71. 2003 Soluble non-classical HLA generated by the metalloproteinase pathway Human Immunol. 64: 802-810, 2.901; 51/119; 17;15
72. 2002 The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 168: 3451-3457. 6.068; 13/119; 31;28
73. 2002 Recruitment of MHC Class I Molecules by Tapasin into the Transporter Associated with Antigen Processing-Associated Complex Is Essential for Optimal Peptide Loading J Immunol. 168: 1950-1960, 6.068; 13/119; 46;46
74. 2002 Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions J. Clin. Invest. 110: 943-953. 16.915; 2/81; 46;30
75. 2002 Characterization of the major histocompatibility complex proteins expression in human embryonic stem cells Proc. Natl. Acad. Sci. USA 99: 9864-9869. 9.598; 3/50; 180;180
76. 2002 CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity J. Immunol. 168: 2803-2810. 6.068; 13/119; 58;41
77. 2001 Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4 J. Immunol, 166: 7260-7267, 6.068; 13/119; 41;27
78. 2001 Recognition of viral hemagglutinins by NKp44 but not by NKp30 Eur.J.Immunol. 31: 2680-2689, 4.662; 19/119; 91;75
79. 2001 Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human natural killer cells Nature. 409: 1055-1060, 28.751; 1/50; 240;206
80. 2001 Molecules in focus: NKp46 Int J Biochem Cell Biol. 33, 1147-1150. 4.009; 67/263; 12;9
81. 2000 The role of NK cells in innate immunity. Adv. Exp. Med. Biol, 479, 137-145; 3; 3. 5;3
82. 2000 N-linked carbohydrate on human leukocyte (HLA)-C and recognition by natural killer cell inhibitory receptors Human Immunol. 61: 1202-1218. 2.901; 51/119; 8;7
83. 1999 HLA-G and its recognition by NK cells J Reprod Immunol. 43: 127-137. 3.011; 48/119; 10;9
84. 1999 Human CD16 as a lysis receptor mediating direct natural killer (NK) cell cytotoxicity. Proc. Natl. Acad. Sci USA. 96: 5640-5644. 9.598; 3/50; 73; 53
85. 1999 The human natural killer cell immune synapse Proc. Natl. Acad. Sci., 96: 15062-15067, 9.598; 3/50; 162;158
86. 1999 The transmembrane sequence of human leukocyte antigen (HLA-) C as a determinant in inhibition of a subset of natural killer cells J. Exp. Med. 189: 1265-1274. 15.612; 5/119; 16;11
87. 1999 The selective downregulation of class I major histocompatibility proteins by HIV-I protects HIV-infected cells from NK cells Immunity, 10: 661-672, 19.266; 4/119; 323;314
88. 1999 Tumor variability and sensitivity to T and NK cells: implications for cancer immunotherapy. K. Kikuchi, B.J. Van den Eynde, and N. Sato (eds.); Recent advances of human tumor immunology and immunotherapy. Gann Monograph on Cancer Research, 48: 105-116, Basel, Karger, Sept
89. 1998 Natural killer activating receptors trigger interferon-secretion from T cells and natural killer cells Proc. Natl. Acad. Sci. USA. 95: 3798-3803. 9.598; 3/50; 43;43
90. 1997 The binding site of NK receptors on HLA-C molecules Immunity. 6: 341-350, 19.266; 4/119; 62;57
91. 1997 Human NK cells: their ligands, receptors and function Immunol Rev. 155: 119-125, 10.536; 6/119; 66;66
92. 1997 Multiple receptors for HLA-G on human natural killer cells Proc. Natl. Acad. Sci. USA. 94: 14666-14670. 9.598; 3/50; 62;56
93. 1997 Impaired spontaneous endocytosis of HLA-G Eur J. Immunol. 27: 2714-2719. 4.662; 19/119; 38;29
94. 1997 Natural Killer cell lines kill autologous 2-microglobulin-deficient melanoma cells: Implications for cancer immunotherapy Proc. Natl. Acad. Sci. USA 94: 13140-13145. 9.598; 3/50; 63;52
95. 1997 Identification of shared tumor associated antigen peptides between two spontaneous lung carcinoma J. Immunol. 159: 6030-6036. 6.068; 13/119; 16;16
96. 1997 Self and viral peptides can initiate lysis by autologous NK cells. Proc. Natl. Acad. Sci. USA. 94: 4604-4609. 9.598; 3/50; 34;30
97. 1997 The class I MHC homologue of human cytomegalovirus inhibits Natural Killer cell attack Nature. 386: 514-517, 28.751; 1/50; 209;206
98. 1996 Protection from natural killer cell-mediated lysis by HLA-G expression on target cells Science. 274: 792-795. 26.372; 2/50; 249;239
99. 1996 Enhancement of class II restricted T cell responses by costimulatory NK receptors for MHC class I proteins Science. 274: 2097-2100. 26.372; 2/50; 79;73
100. 1996 Protection from lysis by NK cells of group 1 and group 2 specificity is mediated by residue 80 in HLA-C alleles and also occurs with 'empty' MHC molecules. J. Exp. Med. 184: 913-922. 15.612; 5/119; 147;104
101. 1995 Expression of two H-2K genes, syngeneic and allogeneic as a strategy for potentiating immune recognition of tumor cells Gene Therapy. 2: 757-765, 4.812; 52/263; 18;18
102. 1995 Regression of established murine carcinoma metastases following vaccination with tumor associated antigen peptides Nature Medicine. 1: 1179-1183, 26.382; 3/263; 106;103
103. 1994 CTL induction by a tumor associated antigen octapeptide derived from a murine lung carcinoma Nature. 369: 67-71, 28.751; 1/50; 205; 201. 223;217
104. 1992 H-2K double transfectants of tumor cells as anti-metastatic cellular vaccines in heterozygous recipients: Implication for T-cell repertoire J. Immunol. 148: 3666-3673, 6.068; 13/119; 20; 17
105. 1992 Genes and antigens controlling tumor metastasis Rabes, H., Peters, H. and Munk, K. (eds): Metastasis: Basic research and its clinical applications. Contrib. Oncol. Basel, Karger, 44: 1-12


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.